Tożsamość

Simvastatin Impurity 22

Nie podano · C24H40O4

01Tożsamość

Lazychem IDLC-28118
CAS RNNie podano
PubChem CID176476964
Molecular formulaC24H40O4
Molecular weight392.6 g/mol
IUPAC name[(1S,3R,7S,8S)-8-[(3R,5S)-3,5-dihydroxyhexyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate
InChIKeyHOWILKPGWHOYSY-YKAZEBNLSA-N

02Struktura i stereochemia

2D structurePubChem CID 176476964
Two-dimensional chemical structure of Simvastatin Impurity 22
Two-dimensional structure for the PubChem identity linked to this record. Confirm the identifiers before analytical use.

The parsed structure contains 2 rings, includes aliphatic carbon, has 6 defined stereocentres. These statements are calculated from the published structure string.

Defined stereocentres6
Ring count2
Secondary amines0
Tertiary amines0
SMILESCCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2C1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](C)O)O)C
InChINie podano

03Stereochemistry

The published structure contains 6 defined and 1 unassigned tetrahedral stereocentres. The exact wedge and dash depiction is shown above.

Defined centres6Structure assigned
Unassigned centres1Structure unspecified
Assignment statusPartially assignedExact published identity
Tetrahedral upper bound≤ 128Before symmetry reduction

Published same-connectivity configurations

1 record

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

No additional structure-linked configuration with the same connectivity is currently present in the LazyChem dataset.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04Status w Indiach

Exact-compound status is evaluated only against the published name and CAS number. Confirm the current official instrument before a regulatory decision.

05Nazwy i powiązania

API i lek macierzysty

Simvastatin

Zanieczyszczenia i związki pokrewne

Nazwy i powiązania

    Zanieczyszczenia i związki pokrewne

    06Źródła